Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Murphy

Showing results (21-30 of 176) with videos related to

Pageof 18
Sort By:
The Journal of Antimicrobial Chemotherapy|December 2, 2015
A Phase 1b/2a study of the safety, pharmacokinetics and antiviral activity of BIT225 in patients with HIV-1 infectionJohn Wilkinson, Gary Ewart, Carolyn Luscombe, et al.
AIDS (London, England)|December 20, 2003
Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week resultsRobert L Murphy, Ian Sanne, Pedro Cahn, et al.
Current Opinion in Biomedical Engineering|September 1, 2020
Supporting Diagnosis and Management of HIV/AIDS Patients Through Point-of-Care Technology DevelopmentSally M McFall, Mamoudou Maiga, Matthew Glucksberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2005
Transient viremia in HIV-infected patients and use of plasma preparation tubesValentina Stosor, Frank J Palella, Baiba Berzins, et al.
AIDS (London, England)|April 14, 2009
Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patientsClaudine Duvivier, Sami Kolta, Lambert Assoumou, et al.
Global Health Innovation|July 19, 2021
C-THAN: A new research center for the development of point-of-care technology for HIV/AIDSSally M McFall, Mamoudou Maiga, Matthew R Glucksberg, et al.
Frontiers in Immunology|October 10, 2022
The need for more holistic immune profiling in next-generation SARS-CoV-2 vaccine trialsRobert L Murphy, Eustache Paramithiotis, Scott Sugden, et al.
The American Journal of Tropical Medicine and Hygiene|November 25, 2015
Clinical Research and the Training of Host Country Investigators: Essential Health Priorities for Disease-Endemic RegionsOusmane A Koita, Robert L Murphy, Saharé Fongoro, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 1, 2009
Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first-line antiretroviral therapy in NigeriaClaudia A Hawkins, Beth Chaplin, John Idoko, et al.
Journal of Medical Systems|February 3, 2021
Suitability of Hood Geometry for Design of a PCM Neonate Incubator for Resource-Limited Clinical ApplicationsEbenezer Olubunmi Ige, Ademola Adebukola Dare, Kayode Anthony Adeniyi, et al.
Pageof 18

Showing results (21-30 of 176) with videos related to

Sort By:
Pageof 18
The Journal of Antimicrobial Chemotherapy|December 2, 2015
A Phase 1b/2a study of the safety, pharmacokinetics and antiviral activity of BIT225 in patients with HIV-1 infectionJohn Wilkinson, Gary Ewart, Carolyn Luscombe, et al.
AIDS (London, England)|December 20, 2003
Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week resultsRobert L Murphy, Ian Sanne, Pedro Cahn, et al.
Current Opinion in Biomedical Engineering|September 1, 2020
Supporting Diagnosis and Management of HIV/AIDS Patients Through Point-of-Care Technology DevelopmentSally M McFall, Mamoudou Maiga, Matthew Glucksberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2005
Transient viremia in HIV-infected patients and use of plasma preparation tubesValentina Stosor, Frank J Palella, Baiba Berzins, et al.
AIDS (London, England)|April 14, 2009
Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patientsClaudine Duvivier, Sami Kolta, Lambert Assoumou, et al.
Global Health Innovation|July 19, 2021
C-THAN: A new research center for the development of point-of-care technology for HIV/AIDSSally M McFall, Mamoudou Maiga, Matthew R Glucksberg, et al.
Frontiers in Immunology|October 10, 2022
The need for more holistic immune profiling in next-generation SARS-CoV-2 vaccine trialsRobert L Murphy, Eustache Paramithiotis, Scott Sugden, et al.
The American Journal of Tropical Medicine and Hygiene|November 25, 2015
Clinical Research and the Training of Host Country Investigators: Essential Health Priorities for Disease-Endemic RegionsOusmane A Koita, Robert L Murphy, Saharé Fongoro, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 1, 2009
Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first-line antiretroviral therapy in NigeriaClaudia A Hawkins, Beth Chaplin, John Idoko, et al.
Journal of Medical Systems|February 3, 2021
Suitability of Hood Geometry for Design of a PCM Neonate Incubator for Resource-Limited Clinical ApplicationsEbenezer Olubunmi Ige, Ademola Adebukola Dare, Kayode Anthony Adeniyi, et al.
Pageof 18